Mounjaro®
Starting from £179.99/mo
Start journey Learn moreThe Mounjaro pen is a pre-filled, multi-dose KwikPen made by Eli Lilly. It holds four weekly doses in a single device, uses a hidden needle mechanism, and is available in six colour-coded strengths from 2.5 mg to 15 mg. As a prescription-only medicine, a clinical assessment by a GPhC-registered prescriber is required before you can access it — but knowing what the pen looks like, how it works, and what to expect after each injection is genuinely useful before you start. The NHS tirzepatide patient page gives a clear overview of the medicine itself.
At your door the next working day.
Free, tracked, plain packaging.
BMI isn't the whole story, but it's where clinicians start. Check yours in ten seconds — nothing is stored, nothing is shared.
Ten seconds. Private — nothing is stored or shared.
Your result updates live in the card alongside.
Your result
Your BMI is
—
which is in the healthy weight range
Start journeyBMI doesn't determine eligibility — only a clinician can assess whether treatment is right for you.
The problem
The nume way
clinician review. Free next working day delivery.
How it works
Tell us about your health, history and goals. Free, online, and confidential — no commitment, no waiting room.
Our team reviews your health the same day — never an algorithm, and approves your treatment there and then if eligible.
Order by 12pm, dispatched same day, delivered free the next working day — the nume Promise.
The KwikPen is roughly the size and weight of a thick marker pen, about 15 cm long, with a clear cylindrical cartridge running through the middle of the body. That window is one of the most important features: through it you can see the liquid solution inside, which should be clear to slightly yellow and free of particles. If it looks cloudy or contains floating matter, the dose should not be used.
The cap at one end is removable and covers a needle port that stays completely hidden until the pen is pressed against skin. There is no exposed needle to worry about during preparation. On the body itself you will find a dose counter showing how many doses remain (starting at four, counting down) and a plunger that sits at the top of the cartridge. The label wrapping the pen body is colour-coded by strength, a detail worth knowing if you ever have more than one pen in the fridge and want to be certain you are picking up the right one.
The pen does not require any assembly. There are no cartridges to load, no needles to attach. You remove the cap, press the pen firmly against your chosen injection site (abdomen, thigh, or upper arm), and press the injection button. The mechanism drives the hidden needle in, delivers the dose, and retracts automatically. Most people describe hearing and feeling a faint click at the start and another at the end, both are confirmation the device has cycled correctly. The full injection typically takes around ten seconds.
This is a question our prescribers hear most weeks, usually from people who want to be certain the dose actually went in. After a successful injection, two things change visibly. First, the dose counter decrements by one: if it showed 4 before, it now shows 3. Second, the plunger inside the cartridge window moves downward by a small, measurable amount, and the liquid level drops accordingly. You will also notice the cap end retracted cleanly, no blood or liquid should appear at the injection site, though a tiny pinprick mark is normal.
If the counter did not change, or the plunger looks identical to before, that is a signal to contact your prescriber before attempting another dose. Giving a second dose in the same week to compensate carries real risks and is never advised without clinical guidance.
Once all four doses have been used, the counter reads zero and the pen locks, it will not fire again. At that point the pen is complete and ready for safe disposal. A properly sealed sharps container is the correct disposal route; household bins are not suitable for used injection devices.
Titration is one of the more practically complex parts of treatment, particularly in the first few months when your prescriber steps you up through the lower strengths to find the right maintenance dose. Eli Lilly's colour-coding system is designed to reduce the chance of picking up the wrong pen at a critical moment.
The six strengths each carry a distinct label colour on both the pen body and the outer carton: 2.5 mg is grey, 5 mg is pink, 7.5 mg is yellow, 10 mg is blue, 12.5 mg is teal, and 15 mg is a deep red. If you are mid-titration and have a remaining 5 mg pen sitting in the fridge door next to the kettle alongside a new 7.5 mg pen, a quick glance at the label is your first safety check before you even look at the dose counter.
Always double-check the printed strength on the label too, especially after a dose change. The four-week lifespan of each pen means most people will be opening a new pen every month, which is exactly when a mix-up between old and new strengths is most likely. You can read more about the KwikPen format and what it contains on the Mounjaro pen overview page.
The needle used with the Mounjaro KwikPen is fine-gauge and short, designed specifically for subcutaneous (under-skin) injection rather than the deeper intramuscular approach used in some other medicines. Because the needle is fully concealed inside the pen body at all times, most people do not find the sight of the device itself anxiety-inducing in the way a visible syringe might be.
What you do feel is a brief pressure as the pen is held against the skin and the button pressed, followed by the injection itself, which most people describe as a mild sting or nothing at all. Rotating injection sites, as described in the Patient Information Leaflet, helps prevent localised reactions building up over time. The needle gauge and length are specified in the Mounjaro SmPC, and your prescriber can walk you through technique at any point. Useful as the pen's design is, no two people's experience is identical, and more detail on the injection process itself is worth reading before your first dose.
If you are considering this treatment for the first time, our Mounjaro overview covers the full picture, from how the medicine works to eligibility and what the cost of treatment looks like privately. When you are ready, speaking to our prescribers is the straightforward next step.
The people
Superintendent Pharmacist (GPhC No. 2217101)
Accountable for the safe running of our registered pharmacy, from every dispensing check to every dispatch.
Clinical Lead (GPhC No. 2231744)
Sets our clinical standards and checks everything we publish against current MHRA guidance.
Independent Prescriber (GPhC No. 2084501)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.
Independent Prescriber (GPhC No. 2083426)
Personally reviews consultations and assesses whether treatment is clinically appropriate, and leads dose adjustments and follow-up checks.